Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $478.77 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $149.21 | 4 | $0 (2024) |
| Novo Nordisk Inc | $132.68 | 6 | $0 (2021) |
| ABBVIE INC. | $72.69 | 4 | $0 (2024) |
| Lilly USA, LLC | $38.77 | 3 | $0 (2021) |
| Medtronic Vascular, Inc. | $23.60 | 1 | $0 (2018) |
| Tandem Diabetes Care, Inc. | $16.62 | 1 | $0 (2018) |
| Allergan Inc. | $12.68 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $11.06 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $10.80 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $10.66 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.12 | 2 | AstraZeneca Pharmaceuticals LP ($110.62) |
| 2023 | $18.90 | 1 | ABBVIE INC. ($18.90) |
| 2021 | $58.34 | 4 | AbbVie Inc. ($34.29) |
| 2019 | $135.08 | 6 | Novo Nordisk Inc ($70.98) |
| 2018 | $136.33 | 10 | Novo Nordisk Inc ($49.07) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $110.62 | General |
| Category: Respiratory | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Neuroscience | ||||||
| 07/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Diabetes | ||||||
| 11/12/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Neuroscience | ||||||
| 10/30/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Neuroscience | ||||||
| 02/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $70.98 | General |
| Category: Diabetes | ||||||
| 12/06/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Diabetes | ||||||
| 10/16/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Diabetes | ||||||
| 10/15/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $10.80 | General |
| 07/19/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Diabetes | ||||||
| 06/18/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.49 | General |
| 06/01/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2018 | Medtronic Vascular, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: EndoVenous Therapies | ||||||
| 04/13/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, BELSOMRA | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/22/2018 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 239 | 420 | $127,450 | $26,361 |
| 2022 | 5 | 244 | 443 | $125,729 | $25,799 |
| 2021 | 3 | 88 | 110 | $12,151 | $2,370 |
| 2020 | 3 | 89 | 113 | $6,578 | $963.20 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 286 | $89,804 | $17,375 | 19.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $9,801 | $3,967 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 73 | $19,053 | $2,950 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 28 | $8,792 | $2,068 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 306 | $96,084 | $20,224 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 83 | $21,663 | $3,626 | 16.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 22 | $2,310 | $754.30 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,342 | $657.67 | 15.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 17 | 19 | $1,330 | $537.09 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 22 | $6,512 | $1,602 | 24.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 53 | 74 | $5,303 | $718.54 | 13.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 14 | $336.00 | $48.72 | 14.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 49 | 72 | $4,824 | $687.70 | 14.3% |
| 83037 | Hemoglobin a1c level | Office | 2020 | 21 | 22 | $1,298 | $210.01 | 16.2% |
| 81002 | Urinalysis, manual test | Office | 2020 | 19 | 19 | $456.00 | $65.49 | 14.4% |
About Dr. Rita Patel, M.D
Dr. Rita Patel, M.D is a Family Medicine healthcare provider based in Saint Albans, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1497195374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rita Patel, M.D has received a total of $478.77 in payments from pharmaceutical and medical device companies, with $130.12 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($478.77).
As a Medicare-enrolled provider, Patel has provided services to 660 Medicare beneficiaries, totaling 1,086 services with total Medicare billing of $55,493. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Saint Albans, WV
- Active Since 06/25/2013
- Last Updated 10/15/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497195374
Products in Payments
- AIRSUPRA (Drug) $110.62
- Ozempic (Drug) $106.55
- EMGALITY (Drug) $38.77
- FARXIGA (Drug) $38.59
- QULIPTA (Drug) $36.64
- UBRELVY (Drug) $36.05
- ClosureFast (Device) $23.60
- t-slim insulin pump (Device) $16.62
- VRAYLAR (Drug) $12.68
- Tresiba (Drug) $12.64
- ANORO (Drug) $11.06
- JANUVIA (Drug) $10.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Saint Albans
Dr. Amy Casto, Do, DO
Family Medicine — Payments: $894.96
Dr. Onyemachi Ajah, Md, MD
Family Medicine — Payments: $734.51
Dr. Eustace Huggins, M.d, M.D
Family Medicine — Payments: $617.46
Ernesto Cantu, D.o, D.O
Family Medicine — Payments: $576.91
I. Elaine Moore, M.d, M.D
Family Medicine — Payments: $484.00
Sarah Conn, Aprn, Fnp-Bc, APRN, FNP-BC
Family Medicine — Payments: $414.81